Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s518617 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yiting Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, People's Republic of China. Hauptthemen laut MEDLINE: Piperazines, Pyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Hebei General Hospital, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, People's Republic of China.
- Department of Gastroenterology and Hepatology, Hebei General Hospital, Shijiazhuang, People's Republic of China.
- Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Shijiazhuang, People's Republic of China.
ORCID-Profile: Wanjun Bai
Zitieren
APA
Hu, Y., Zhao, N., Song, H., Zhang, J., Bi, L., Qiu, B., Xu, Y., Jia, C., & Bai, W. (2025). Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s518617
Vancouver
Hu Y, Zhao N, Song H, Zhang J, Bi L, Qiu B, et al. Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s518617
BibTeX
@article{Hu2025,
author = {Hu, Yiting and Zhao, Na and Song, Haojing and Zhang, Jian and Bi, Lusha and Qiu, Bo and Xu, Yufang and Jia, Caiyun and Bai, Wanjun},
title = {Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s518617}
}
EUVIMED